Breaking News Instant updates and real-time market news.

CRBP

Corbus Pharmaceuticals

$8.25

0.45 (5.77%)

07:38
11/29/16
11/29
07:38
11/29/16
07:38

Corbus commencing one-year open-label extension to Resunab phase 2 study

Corbus Pharmaceuticals announced that it is commencing a one-year, open-label extension study of the ongoing Phase 2 clinical study of Resunab, JBT-101, for the treatment of skin-predominant dermatomyositis. This open-label extension was submitted to and reviewed by the U.S. FDA. The goal of the open-label extension dermatomyositis study is to provide all enrolled subjects with the option of receiving JBT-101 for one year after they complete the four-month, double-blind placebo controlled portion of the study and to collect long-term safety and efficacy on JBT-101. The safety and efficacy endpoints used in the double-blinded, placebo-controlled portion of the study will be assessed throughout the one year extension study. The Phase 2 study in skin-predominant dermatomyositis is funded by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health to the University of Pennsylvania School of Medicine.

CRBP Corbus Pharmaceuticals
$8.25

0.45 (5.77%)

09/19/16
AGIS
09/19/16
NO CHANGE
Target $12
AGIS
Buy
Corbus Pharmaceuticals price target raised to $12 from $7 at Aegis
Aegis analyst Robert Leboyer raised his price target for Corbus Pharmaceuticals to $12 from $7 and keeps a Buy rating on the name.
10/04/16
CANT
10/04/16
INITIATION
Target $17
CANT
Buy
Corbus Pharmaceuticals initiated with a Buy at Cantor
Cantor initiated Corbus Pharmaceuticals with a Buy and a $17 price target.
10/25/16
NBLE
10/25/16
NO CHANGE
NBLE
Corbus Pharmaceuticals risk/reward remains favorable, says Noble Financial
Noble Financial analyst Kumaraguru Raja remains bullish on Corbus' Resunab being developed for treating inflammation and fibrosis as it preferentially targets CB2 receptor; saying preliminary positive data in healthy volunteers validates role in inflammation resolution. The analyst said Resunab has better anti-inflammatory activity even in low doses adn the open-label extension indicates the FDA comfort with safety and efficacy. Raja likes Corbus' risk/reward heading into multiple data readouts and reiterates his Buy rating and $19 price target on shares.
11/15/16
JMPS
11/15/16
NO CHANGE
JMPS
Corbus Pharmaceuticals price target raised to $20 from $9 at JMP Securities
JMP Securities analyst Liisa Bayko raised her price target on Corbus as she believes that data on the company's Resunab drug for scleroderma indicates that its efficacy could be significantly positive, while its safety/tolerability could be "favorable." Bayko keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

AAPL

Apple

$151.89

-1.5 (-0.98%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

13:10
09/25/17
09/25
13:10
09/25/17
13:10
Periodicals
Apple switches Siri search results to Google from Bing, TechCrunch says »

Apple (AAPL) will now use…

AAPL

Apple

$151.89

-1.5 (-0.98%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

CATM

Cardtronics

$29.27

0.16 (0.55%)

13:09
09/25/17
09/25
13:09
09/25/17
13:09
Recommendations
Cardtronics analyst commentary  »

Cardtronics selloff feels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATM

Cardtronics

$29.27

0.16 (0.55%)

13:05
09/25/17
09/25
13:05
09/25/17
13:05
Recommendations
Cardtronics analyst commentary  »

Cardtronics selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$111.78

-0.51 (-0.45%)

13:05
09/25/17
09/25
13:05
09/25/17
13:05
Options
Autodesk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMT

America's Car-Mart

$40.85

0.35 (0.86%)

12:59
09/25/17
09/25
12:59
09/25/17
12:59
Conference/Events
America's Car-Mart management to meet with Sidoti »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

NAV

Navistar

$41.68

0.35 (0.85%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:58
09/25/17
09/25
12:58
09/25/17
12:58
Periodicals
Navistar, Volkswagen Truck to launch electric medium duty truck, Reuters reports »

Navistar International…

NAV

Navistar

$41.68

0.35 (0.85%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

ICPT

Intercept

$61.59

-12.11 (-16.43%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Recommendations
Intercept analyst commentary  »

Intercept recent weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

YNDX

Yandex

$33.20

0.57 (1.75%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Options
Yandex put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUS

ePlus

$88.60

1.05 (1.20%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Conference/Events
ePlus management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PKY

Parkway

$23.04

0.02 (0.09%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Conference/Events
Parkway to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MOH

Molina Healthcare

$64.59

-0.735 (-1.13%)

, UNH

UnitedHealth

$191.32

-1.7138 (-0.89%)

12:50
09/25/17
09/25
12:50
09/25/17
12:50
Periodicals
Sen. Ted Cruz still opposes Graham-Cassidy bill, Axios reports »

Senator Ted Cruz remains…

MOH

Molina Healthcare

$64.59

-0.735 (-1.13%)

UNH

UnitedHealth

$191.32

-1.7138 (-0.89%)

CNC

Centene

$90.60

-1.62 (-1.76%)

WCG

WellCare

$165.67

-1.49 (-0.89%)

CI

Cigna

$181.69

-1.05 (-0.57%)

ANTM

Anthem

$182.89

0.03 (0.02%)

HNT

Health Net

HUM

Humana

$238.48

-0.6125 (-0.26%)

AET

Aetna

$152.55

-1.02 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SOL

ReneSola

$2.17

-0.0508 (-2.29%)

12:49
09/25/17
09/25
12:49
09/25/17
12:49
Hot Stocks
ReneSola agrees to disposition of manufacturing, LED distribution units »

ReneSola announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEX

Alexander & Baldwin

$45.23

0.26 (0.58%)

12:49
09/25/17
09/25
12:49
09/25/17
12:49
Conference/Events
Alexander & Baldwin management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

FB

Facebook

$170.54

-0.57 (-0.33%)

12:47
09/25/17
09/25
12:47
09/25/17
12:47
Periodicals
China blocks WhatsApp ahead of Communist Party gathering, NY Times reports »

China has mostly blocked…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

HES

Hess Corp.

$45.45

0.95 (2.13%)

12:45
09/25/17
09/25
12:45
09/25/17
12:45
Options
Hess Corp. call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

C

Citi

$70.60

-0.8 (-1.12%)

12:43
09/25/17
09/25
12:43
09/25/17
12:43
Hot Stocks
Citibank, CGML ordered to pay $550,000 penalty by CFTC »

The U.S. Commodity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

UFPI

Universal Forest

$94.65

2.47 (2.68%)

12:41
09/25/17
09/25
12:41
09/25/17
12:41
Conference/Events
Universal Forest management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

NAV

Navistar

$42.09

0.755 (1.83%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:40
09/25/17
09/25
12:40
09/25/17
12:40
Periodicals
Breaking Periodicals news story on Navistar, Volkswagen »

Navistar, Volkswagen…

NAV

Navistar

$42.09

0.755 (1.83%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

DRI

Darden

$82.45

-0.43 (-0.52%)

, FDS

FactSet

$167.38

-1.23 (-0.73%)

12:40
09/25/17
09/25
12:40
09/25/17
12:40
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$82.45

-0.43 (-0.52%)

FDS

FactSet

$167.38

-1.23 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

NAV

Navistar

$42.05

0.72 (1.74%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:39
09/25/17
09/25
12:39
09/25/17
12:39
Hot Stocks
Navistar announces collaboration with Volkswagen Truck & Bus »

Navistar (NAV) announced…

NAV

Navistar

$42.05

0.72 (1.74%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

F

Ford

$11.88

0.035 (0.30%)

12:38
09/25/17
09/25
12:38
09/25/17
12:38
Periodicals
NFL sponsor Ford issues statement supporting free speech, Bloomberg says »

Following a string of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

  • 26

    Oct

BGG

Briggs & Stratton

$22.70

0.01 (0.04%)

12:35
09/25/17
09/25
12:35
09/25/17
12:35
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ICPT

Intercept

$61.59

-12.11 (-16.43%)

12:34
09/25/17
09/25
12:34
09/25/17
12:34
Recommendations
Intercept analyst commentary  »

Jefferies cuts Intercept…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLAKY

Lufthansa

$27.31

-0.1 (-0.36%)

, MKGAY

Merck KGaA

12:33
09/25/17
09/25
12:33
09/25/17
12:33
Hot Stocks
Lufthansa chairman Mayrhuber resigns, Kley named new chairman »

Prior to today's…

DLAKY

Lufthansa

$27.31

-0.1 (-0.36%)

MKGAY

Merck KGaA

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAWW

Atlas Air

$67.60

0.15 (0.22%)

12:32
09/25/17
09/25
12:32
09/25/17
12:32
Hot Stocks
Atlas Air, Polar Air Cargo seek preliminary injunction to stop work slowdown »

Atlas Air and Polar Air…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.